Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario La Fe (20)

2024

  1. Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis

    Survey of Ophthalmology, Vol. 69, Núm. 4, pp. 585-605

2021

  1. MUC4 is overexpressed in idiopathic pulmonary fibrosis and collaborates with transforming growth factor β inducing fibrotic responses

    Mucosal Immunology, Vol. 14, Núm. 2, pp. 377-388

2019

  1. In vitro anti-inflammatory effects of AZD8999, a novel bifunctional muscarinic acetylcholine receptor antagonist /β2-adrenoceptor agonist (MABA) compound in neutrophils from COPD patients

    PLoS ONE, Vol. 14, Núm. 1

  2. MUC1 intracellular bioactivation mediates lung fibrosis

    Thorax, Vol. 75, Núm. 2, pp. 132-142

  3. Mucin 1 deficiency mediates corticosteroid insensitivity in asthma

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 74, Núm. 1, pp. 111-121

2018

  1. JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study

    Thorax, Vol. 73, Núm. 6, pp. 519-529

  2. The JAK2 pathway is activated in idiopathic pulmonary fibrosis

    Respiratory Research, Vol. 19, Núm. 1

2016

  1. Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients

    Respiratory Research, Vol. 17, Núm. 1

  2. Vascular effects of sildenafil in patients with pulmonary fibrosis and pulmonary hypertension: An ex vivo/in vitro study

    European Respiratory Journal, Vol. 47, Núm. 6, pp. 1737-1749

2011

  1. Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia

    European Respiratory Journal, Vol. 38, Núm. 5, pp. 1158-1164

2006

  1. Electrophysiologic evaluation of phrenic nerve and diaphragm function after coronary bypass surgery: Prospective study of diabetes and other risk factors

    Journal of Thoracic and Cardiovascular Surgery, Vol. 132, Núm. 3

2001

  1. Biotransformation in vitro of the 22R and 22S epimers of budesonide by human liver, bronchus, colonic mucosa and skin

    Fundamental and Clinical Pharmacology, Vol. 15, Núm. 1, pp. 47-54

1996

  1. Effect of serotonin and calcium in normal and sensitized guinea pig isolated trachea

    Fundamental and Clinical Pharmacology, Vol. 10, Núm. 1, pp. 33-37

1993

  1. Pharmacological modulation of the spasmogenic response to methylxanthines in guinea-pig trachea

    Research Communications in Chemical Pathology and Pharmacology, Vol. 79, Núm. 1, pp. 125-128

1991

  1. ESTUDIO DE LA CONTRACTILIDAD DIAFRAGMATICA EN UN MODELO DE ASMA EXPERIMENTAL. EFECTOS DE LAS METILXANTINAS

    Archivos de Bronconeumologia, Vol. 27, Núm. 6, pp. 249-253

  2. Hyperreactivity and 45Ca movements in sensitized guinea-pig tracheal muscle

    European Respiratory Journal, Vol. 4, Núm. 4, pp. 450-457

1990

  1. Calcium and diaphragmatic contractility. Modification by methylxantines

    Archivos de Bronconeumologia, Vol. 26, Núm. 8, pp. 434-345

  2. Differential calcium uptake in tracheal smooth muscle from normal and sensitised guinea-pigs

    Medical Science Research, Vol. 18, Núm. 4, pp. 127-128

  3. Relationship between nonspecific airway hyperreactivity and antigen-induced contraction in an allergic animal model in vitro

    Respiration, Vol. 57, Núm. 2, pp. 81-84

1989

  1. Sources of calcium for the contraction induced by various agonists in trachealis muscle from normal and sensitized guinea pigs

    Respiration, Vol. 55, Núm. 2, pp. 105-112